Kanabo Group PLC - London-based medicinal cannabis firm that listed in February - Signs agreement with PharmaCann Polska allowing PharmaCann to supply cartridges containing Kanabo's proprietary medicinal cannabis formulations for its VapePod inhalation device. Notes this is Kanabo's second key agreement directed towards establishing a European medicinal cannabis supply chain. Says the cartridges will be filled and prepared at PharmaCann's facility in North Macedonia.
"Following the increased fund-raise achieved at the [initial public offering], we are able to accelerate preparations for supply of medicinal cannabis products in addition to building our CBD Wellness business. I am delighted to work with PharmaCann which will enable us to provide medical cannabis vape products to thousands of patients safely and effectively using our medical grade VapePod device," says Kanabo Chief Executive Avihu Tamir.
Current stock price: 22.00 pence, up from 18.50p on February 16
By Zoe Wickens; zoewickens@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.